Rationale and Objectives: Perturbations in cerebral blood volume (CBV), blood flow (CBF), and metabolic rate of oxygen (CMRO 2 ) lead to associated changes in tissue concentrations of oxy-and deoxy-hemoglobin (DO and DD), which can be measured by near-infrared spectroscopy (NIRS). A novel hemodynamic model has been introduced to relate physiological perturbations and measured quantities. We seek to use this model to determine functional traces of cbv(t) and cbf(t) À cmro 2 (t) from time-varying NIRS data, and cerebrovascular physiological parameters from oscillatory NIRS data (lowercase letters denote the relative changes in CBV, CBF, and CMRO 2 with respect to baseline). Such a practical implementation of a quantitative hemodynamic model is an important step toward the clinical translation of NIRS.
N ear-infrared spectroscopy (NIRS) can assess noninvasively cerebral hemodynamics and brain function by being sensitive to cerebral concentrations of deoxyhemoglobin (D) and oxy-hemoglobin (O). Noninvasive measurements of task-related functional activity with NIRS, or fNIRS, have been reported (1) (2) (3) . These hemodynamic changes result from changes in the cerebral blood volume (CBV), cerebral blood flow (CBF), and metabolic rate of oxygen (CMRO 2 ) as a result of brain activation and neurovascular coupling. Understanding the interplay between these physiological/functional/metabolic processes and the measured signals with functional neuroimaging techniques such as fNIRS and functional magnetic resonance imaging is the major objective of hemodynamic models (for a review, see Buxton, 2012 (4) ).
A novel hemodynamic model has been recently introduced to provide an analytical tool for the study of oscillatory (frequency domain) and time varying (time domain) hemodynamics that are measurable with NIRS (5). The model relates normalized perturbations in CBV, CBF, and CMRO 2 to the dynamics of O and D concentrations in tissue. In particular, this model treats the cerebral microvasculature in terms of three compartments (arterial, capillary, venous) and describes the effects of changes in blood volume in all three compartments (even though the capillary contribution to blood volume changes may be negligible), and the effects of changes in blood flow and metabolic rate of oxygen in the capillary compartment (direct effects) and the venous compartment (indirect effects). This novel model can be applied to measurements in the time domain (O(t), D(t)), where hemodynamic changes are induced over time, and in the frequency domain (via the phasors O(u), D(u)), where induced hemodynamic oscillations are measured as a function of the frequency of oscillation. Hemodynamic oscillations at a specific frequency can be induced by a number of protocols including paced breathing (6) , headup-tilting (7), squat-stand maneuvers (8) , and pneumatic thighcuff inflation (9) , leading to a technique that we have recently proposed, coherent hemodynamics spectroscopy (CHS) (5, 10) .
In this article, we use a new formulation of this hemodynamic model by Fantini (11) to develop its practical implementation for NIRS and fNIRS measurements. In the time domain, we show how the model can be used to translate time traces of O(t) and D(t) into time-varying measures of cbv(t) and the difference cbf(t) À cmro 2 (t)*. In the frequency domain, we demonstrate how the model can be used to measure a number of physiologically relevant parameters such as the blood transit time in the microvasculature and the cutoff frequency for cerebral autoregulation. The work presented here demonstrates, in practical terms, that the new hemodynamic model is a workable model for translation of NIRS measurements into functional and physiological parameters. The feasibility of a practical implementation of this mathematical model, in combination with noninvasive NIRS and fNIRS measurements, is a critical element for its translation toward functional and clinical studies.
HEMODYNAMIC MODEL
In the time domain, all of the time-dependent quantities are represented by time varying real functions. In the frequency domain, all of the oscillatory quantities are represented by phasors (5) . In the following sections, we discuss how the model equations can be implemented in practice to measure (1) the time dependence of the CBV, and a combination of CBF and CMRO 2 associated with brain activation (functional neuroimaging) or (2) a set of physiological parameters on the basis of frequency-resolved measurements of the amplitude and phase of hemodynamic oscillations (CHS).
Time domain equations
We denote with lowercase letters the relative changes in CBV, CBF, and CMRO 2 with respect to baseline (cbvðtÞ ¼ DCBVðtÞ=CBV 0 , cbf ðtÞ ¼ DCBFðtÞ=CBF 0 , cmro 2 ðtÞ ¼ DCMRO 2 ðtÞ=CMRO 2 j 0 ), where DCBV(t) = CBV(t) À CBV 0 , DCBF = CBF(t) À CBF 0 , and DCMRO 2 = CMRO 2 (t) À CMRO 2j0 . The time-dependent expressions for the absolute tissue concentrations of O(t), D(t), and total hemoglobin (T(t)) are given by (11):
Note that the right sides of Equations (1)- (3) are given by the sum of time-independent terms (which correspond to the baseline values O 0 in Eq. (1), D 0 in Eq. (2), and T 0 in Eq. (3)) and time-dependent terms associated with cbv ðaÞ ðtÞ, cbv ðvÞ ðtÞ, cbvðtÞ, cbf ðtÞ, and cmro 2 ðtÞ. Explicitly, the time-independent, baseline concentrations of O, D, and T are given by: 
in which H(t) is the Heaviside unit step function-H(t) = 0 for t < 0; H(t) = 1 for t $ 0. We note that both impulse responses are convolved with cbf ðtÞ À cmro 2 ðtÞ in Equations (1) and (2), as indicated by the convolution operatorÃ.
Measuring the Time Course of cbv and the Difference cbf-cmro 2 In a practical implementation of this hemodynamic model in the time domain, one would like to derive the temporal dynamics of CBV, CBF, and CMRO 2 from the measured time traces of the concentrations of O and D. Equation (3) provides a direct measurement of cbv(t) in terms of the relative change in T with respect to the baseline value T 0 ¼ ctHbCBV 0 :
The convolution operator in Equations (1) and (2) introduces a computational complication that can be addressed by Fourier transformation, which converts convolution products into regular products. By denoting the Fourier transforms with tildes and introducing the angular frequency u, the difference of the Fourier transformed Equations (1) and (2) 
To apply Equation (10) Þ. This analysis shows that it is not possible to disentangle the contributions of the arterial and venous compartments to the dynamics of the overall cbv(t) because, according to Equations (9) and (13), the change in total hemoglobin concentration (which is measured) is related to a weighted average of the blood volume perturbations in the individual compartments. Furthermore, the model shows that only the difference, cbf(t) À cmro 2 (t), can be measured by NIRS. We observe that these restrictions are not specific to the model used, but are intrinsic to any technique that measures the cerebral concentrations of O and D.
Frequency Domain Equations
In the frequency domain, the model describes sinusoidal oscillations at a given angular frequency u. Following the convention of Fantini's work (5), oscillatory quantities are represented by phasors that are indicated in bold type. The model expressions for O(u), D(u), T(u) (i.e., the phasors that describe the oscillations of O, D, and T concentrations) as a function of cbv(u), cbf(u), and cmro 2 (u) (i.e., the phasors that describe the oscillations of CBV, CBF, and CMRO 2 ) are as follows (11) : (11) and (12), and we have set cbv ðcÞ ðuÞ ¼ 0 because of the negligible dynamic dilation and recruitment of capillaries in brain tissue (12) (13) (14) (15) (16) (17) . The notation in Equations (16)- (18) matches that in Equations (1)- (3), and we stress that the cbv, cbf, and cmro 2 phasors are all dimensionless, with their magnitude indicating the amplitude of oscillations normalized to the average, or baseline, values. Because of the high-pass nature of the cerebral autoregulation process that regulates CBF in response to blood pressure changes (19) (20) (21) , we consider the following relationship between cbf and cbv (5): 
in which k is the inverse of the modified Grubb exponent, H ðAutoRegÞ RCÀHP ðuÞ is the RC high-pass transfer function with cutoff frequency u ðAutoRegÞ c that describes the effect of autoregulation, and the second equalities follows from Equation (13) . More precisely, the expression of the RC high-pass transfer function is: 
We observe that, while O(t), D(t), and T(t) in the time domain (Eqs. (1)- (3) 
and T(u) of Equations (16)- (18) represent oscillations about baseline values.
Measuring Physiological Parameters with CHS
Fourteen physiological parameters appear in the expressions for O(u), D(u), and T(u) (Eqs. (16)- (18) , and k. A new method for the assessment of cerebral hemodynamics, CHS, is based on the frequency-resolved measurement of induced hemodynamic oscillations (5) and potentially allows for the measurements of these parameters. Because it is impractical, and in some cases impossible, to control the amplitude and the phase of induced hemodynamic oscillations at different frequencies, we consider the following phasor ratios, thereby canceling unknown common amplitude or phase factors:
OðuÞ
Furthermore, if the induced hemodynamic oscillations do not involve modulation of the cerebral metabolic rate of oxygen, one can assume cmro 2 ðuÞ ¼ 0, so that the model Equations (16)- (18) , in conjunction with Equation (19) , yield the following expressions for the phasor ratios of Equations (21) and (22): A first observation is that, contrary to the time domain case, by taking the phasor ratios D/O and O/T, we do not have access to cbv(u). In fact, the blood volume phasor cbv(u) contains an unknown frequency-dependent term related to the variability of the amplitude of the induced hemodynamic oscillations as a function of frequency, which cancels out in the ratios cbv ðaÞ ðuÞ=cbv ðvÞ ðuÞ that appear in Equations (23) and (24) . Similar to the time domain case, we assume that the blood volume of the arterial and venous compartments have the same frequency dependence, and we take the phase of (23) and (24) . A second observation is that of the 14 model parameters, one (ctHb) has canceled out in Equations (23) and (24), and the remaining 13 are combined in Equations (23) and (24) 
METHODS

Time Domain
The goal of this work for the time domain is to demonstrate in practical terms how the novel hemodynamic model introduced by Fantini (5,11) can be applied to time-varying (9) and (10) show that fNIRS can lead to measures of blood volume, cbv(t), and the difference, cbf ðtÞ À cmro 2 ðtÞ, not cbf ðtÞ and cmro 2 ðtÞ separately. To this aim, we have used simulated data for O(t) and D(t). There are several mathematical functions that have been proposed to describe hemodynamic changes during functional brain activation (23) (24) (25) (26) (27) . Often used for describing the functional magnetic resonance imaging blood oxygen level-dependent signal as a hemodynamic response function consisting of one or two gamma functions (26) . Here we have chosen the following expression for simulating the temporal traces of DO(t) and DD(t):
in which y(t) stands for either DO(t) or DD(t), t is time, and t 0 is the time at which brain activation starts. G represents the gamma function, which acts as a normalizing parameter, and d and b are constants for which we set values of d = 8 and b = 0.6 seconds
À1
. The amplitude A was set to 3 mMs for DO(t) and À1 mMs for DD(t). These parameters were chosen to best represent typical hemodynamic signals during activation (2, (28) (29) (30) , as seen in Figure 1a , where the DO(t) and DD(t) traces peak simultaneously at t À t 0 = 11.7s. We set the baseline total hemoglobin concentration T 0 = 55 mM and the baseline tissue saturation S 0 = 65%. These values fall within typical values reported in the literature for the human brain, which range between 42 and 79 mM for T 0 , and between 55 and 75% for S 0 (31) (32) (33) (34) (35) (36) . Because the hemodynamic model depends on several parameters (as described previously), we have studied the sensitivity of cbf ðtÞ À cmro 2 ðtÞ on the values assigned to these parameters. We further compared the model output with a steady-state approach that has been used extensively in the literature (37) (38) (39) (40) (41) . In comparison to the dynamic model (5,11), a steady-state model does not consider any temporal shifts between cbf(t)-or cmro 2 (t)-and DO(t) or DD(t). 
in which g r and g t have been assumed to be constants within the range 0.2 to 5 (41) and D (v) j 0 and T (v) j 0 are the baseline deoxy hemoglobin concentration and total hemoglobin concentration in the venous compartment, respectively. Equation (26) fits in the definition of steady-state models because it introduces no temporal shift between the changes in the D and T hemoglobin concentrations (D (v) , T (v) ), and the blood flow and oxygen consumption perturbations (cbf(t), cmro 2 (t)) that cause them. Recently, Fantini (11) derived the following explicit expressions for the coefficients g r and g t , under the approximation ð1 À S ðaÞ Þy0: 
Using Equations (26)- (28), one can determine the cbf ðtÞ À cmro 2 ðtÞ traces derived using the steady-state approach and compare them to those derived using the hemodynamic model of Fantini. , F ahraeus factor in capillaries; blood transit time in capillaries; t, time; t (v) , venous blood transit time.
Frequency Domain
The goal of this work for the frequency domain is to demonstrate in practical terms how the novel hemodynamic model introduced by Fantini (5) can be applied to frequencyresolved measurements of induced hemodynamic oscillations to determine the following independent combinations of model parameters: (the rate constant for oxygen diffusion from the capillary bed to tissue). The methods of obtaining such frequency resolved spectra (CHS) has been described previously (5,10). Here we perform a new analysis of previously collected paced breathing data, which we are analyzing with the novel description of the model in terms of cbf(u) and cbv(u) (Eqs. (23) and (24)). Details about the data acquisition methods have been reported previously (10) and are described only briefly here. NIRS measurements were performed with a commercial tissue oximeter (OxiplexTS, ISS, Inc., Champaign, IL) on 11 healthy subjects. The optical probe was placed on the right side of the subject's forehead. Subjects were asked to perform paced breathing, guided by a metronome. Five subjects performed paced breathing at 11 frequencies (0.071, 0.077, 0.083, 0.091, 0.100, 0.111, 0.125, 0.143, 0.167, 0.200, and 0.250 Hz). Six subjects performed paced breathing at four frequencies (0.071, 0.100, 0.167, and 0.250 Hz). After slow temporal drifts were removed from the data, band-pass filtering was performed around each paced breathing frequency. Based on phasor analysis and using this band-pass filtered data, we could obtain jDj/jOj, jOj/jTj, arg(D) À arg(O), and arg(O) À arg(T) for each paced breathing frequency (with arg describing the angle). For the purpose of this work, we have calculated the average and standard error of the data collected on all 11 subjects. The experimental protocol was approved by the institutional review board, and written informed consent was obtained from all participants before the study. After setting S ðaÞ = 0.98 and a = 0.8 seconds À1 , we are left with six unknown parameters t (c) , t (23) and (24)). We have used a built-in fitting procedure in MATLAB (function ''lsqcurvefit'') with the default reconstruction algorithm, which is a trust region reflective algorithm. This algorithm allows one to carry out a reconstruction of the six unknowns by searching within a bounded region of the six parameters' space. The fitting procedure considers as known or input values the four parameters jDj/jOj, jOj/jTj, arg(D) À arg(O), and arg(O) À arg(T) (measured at multiple frequencies) and finds the optimal set of the six unknown parameters by minimizing a cost function (c 2 ) that is the sum of the residuals squared. The phase differences were expressed in radians, so that the four different input quantities were of the same order of magnitude. For the fitting procedure, we have set upper and lower limits on the parameters as summarized in Table 1 . The lower and upper limits were based on physiological ranges for these parameters. The limits for t (c) (0.4-1.4 seconds) were set by requiring that the venous saturation be bound between 32 and 71%. The limits for t (v) correspond to a range of venule lengths of 1 to 3 mm assuming a typical speed of blood flow in venules of 1 mm/s (43) . The limits of (0.8-2.4) for the capillary to venous blood volume times the F ahraeus factor (set to 0.8) correspond to the reported range of $(0.3-0.65) for the capillary to total blood volume over cortical depths of 0-2.5 mm (44) after assuming that overall arteriole and venule blood volumes are the same. This latter assumption also results in the limits for , contributions from arterial compartments; (c) , contributions from capillary compartments; CBV, cerebral blood volume; cbv, relative change in CBV with respect to baseline; k, inverse of the modified Grubb exponent; t (c) , capillary blood transit time in seconds (s); t, time; (v) , contributions from venous compartments; u c , cutoff frequency of autoregulation.
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RESULTS
Time Domain Results for cbv(t) and cbf (t) À cmro 2 (t)
To obtain the cbvðtÞ traces, Equation (9) was applied and DT(t) was obtained from the sum of DO(t) and DD(t) (Figure 1a) . The corresponding time traces can be seen in Figure 1b (dashed line). To obtain the cbf ðtÞ À cmro 2 ðtÞ traces, DO(t) and DD(t) were first normalized to the baseline total hemoglobin T 0 = 55 mM (Figure 1a) . Then, we set the model parameters to typical values obtained from the literature (5 (14) and (15)). Taking the fast Fourier transform (FFT) of DO(t) and DD(t), we found g cbf ðuÞ À g cmro 2 ðuÞ from Equation (10) , and by applying an inverse FFT (FFT À1 ), we found cbf ðtÞ À cmro 2 ðtÞ as shown in Figure 1b . The determination of cbv(t) is model-independent and only depends on DT(t) and T 0 as shown by Equation (9) . To determine the sensitivity of the derived trace of cbf ðtÞ À cmro 2 ðtÞ on the assumed values for the model parameters, we have considered multiple values of the input parameters. First, the sensitivity to the capillary transit time, t ðcÞ , was evaluated (Figure 2a) . Keeping all other parameters fixed to the values used to generate Figure 1 , we assumed a range of the tissue saturation S 0 from 75 to 55%, which correspond, according to Equation (29) , to a range for t ðcÞ of 0.8 to 1.8 seconds. The associated variability in the derived traces of cbf ðtÞ À cmro 2 ðtÞ can be seen in Figure 2a (solid light gray lines). The magnitude of cbf ðtÞ À cmro 2 ðtÞ ranges from 0.07 for t ðcÞ ¼ 1:8s to 0.11 for t ðcÞ ¼ 0:8s. The steady-state solution of cbf ðtÞ À cmro 2 ðtÞ was also determined by using Equations (26)- (28) with the traces of DO(t) and DD(t). In comparison to the dynamic model, the steady-state solutions (dashed black lines) show the same magnitude change, with g r varying between 0:86 and 0:99 and g t varying between 0:86 and 1:04. In addition, the peak time for cbf ðtÞ À cmro 2 ðtÞ differs between the dynamic model prediction and the steadystate solutions as seen in the inset of Figure 2a . By definition, the steady-state prediction shows a peak time coincident with the peak times of DO(t) and DD(t). The dynamic model, however, predicts an earlier rising of cbf ðtÞ À cmro 2 ðtÞ in comparison to DO(t) and DD(t), with peak times preceding the hemoglobin signals by 0.9 seconds for t ðcÞ ¼ 0:8s and 1.2 seconds for t ðcÞ ¼ 1:8s. This temporal lead of the physiological changes (cbf ðtÞ À cmro 2 ðtÞ) with respect to the measured signals DO(t) and DD(t) is the result of the blood transit time in the microvasculature.
We have set a = 0.8 seconds human gray matter (51) (52) (53) . These reported measured ranges for D and d lead to a range of possible oxygen diffusion rate constants a of 0.4 to 1.2 seconds À1 . We have evaluated the influence of a by keeping the baseline tissue saturation S 0 constant at 65%. Based on Equation (29), the capillary transit time for a given a was calculated and the corresponding cbf ðtÞ À cmro 2 ðtÞ traces were obtained (data not shown). We found that the magnitude of cbf ðtÞ À cmro 2 ðtÞ was independent of the value of a, provided that the product at ðcÞ is kept constant. However, the peak time of cbf ðtÞ À cmro 2 ðtÞ varied by 400 ms because of the variability in t ðcÞ .
The effect of changing the venous transit time t ðvÞ between 1 and 3 seconds can be seen in Figure 2b , where again we kept constant all other model parameters and the baseline tissue saturation, which was set to S 0 = 65%. A change in magnitude as well as in peak time of cbf ðtÞ À cmro 2 ðtÞ can be seen. However, the effect of changing t ðvÞ is negligible in comparison to the effect of t ðcÞ . For the steady-state solutions, we found g r ¼ 0:93 and g t ¼ 0:96. According to the dynamic model, changing the capillary-to-total blood volume ratio, CBV ðcÞ 0 CBV 0 , between 0.3 and 0.65, we observe a magnitude change between 0.08 and 0.09 and a change in peak time that precedes by 0.9 to 1.3 s the peak time of DO(t) and DD(t) as seen in Figure 2c . Again, the steady-state solutions show comparable magnitudes, with g r within the range 0.93-0.97 and g t within the range 0.96-0.99. Last, changing the arterialto-venous blood volume ratio, did not result in a magnitude change in the dynamic model determination of cbf ðtÞ À cmro 2 ðtÞ, as seen in Figure 2d . The peak times were only slightly affected, ranging from 0.97 to 1.05 seconds. Also in this case, the steady-state solutions show a comparable magnitude, with g r within the range 0.93-0.94 and g t within the range 0.91-1.02. Figure 3 shows the experimental results of the average data set from 11 paced breathing subjects, with the data points being the mean values of the data collected on the 11 subjects and the error bars showing the standard error. Launching 54 initial guesses for the six parameters of the fitting procedure, we found 54 times the same final values with the same , contributions from arterial compartments; (c) , contributions from capillary compartments; CBV, cerebral blood volume; cbv, relative change in CBV with respect to baseline; k, inverse of the modified Grubb exponent; t (c) , capillary blood transit time in seconds (s); t, time; (v) , contributions from venous compartments; u c , cutoff frequency of autoregulation. although the solution with the smallest c 2 value is a robust solution in terms of independence of the initial guess, there are other solutions with marginally larger c 2 values that also result in good fits to the data. Because the fitting procedure used did not provide errors of the solutions and did not take the standard error of the experimental data into account, we included a number of solutions for each parameter corresponding to a range of c 2 values, with the criteria being that the fit for jDj/jOj, jOj/jTj, arg(D) À arg(O), and arg(O) À arg(T) goes through all the experimental data points and their error bars.
Frequency Domain Results
The shaded area in Figure 3 contains all the spectra for jDj/ jOj, jOj/jTj, arg(D) À arg(O), and arg(O) À arg(T) for a set of solutions for the six parameters that results in c 2 values that are within a range of 0.02 (the minimum c 2 ) to 0.15. The solutions for the data set shown in Figure 3 are summarized in Table 2 , where we report the mean value and standard deviation of the set of acceptable values for each parameter. The cutoff frequency, u ðAutoRegÞ c =ð2pÞ, which provides a measure of the efficiency of cerebral autoregulation, shows the smallest relative standard deviation (5.7%) of all six parameters.
As in the time domain, we kept a = 0.8 s
À1
. However, as discussed previously, a may vary between $0.4 and 1.2 s
. We evaluated the dependence of the frequency domain results on a by making it an independent parameter in the fit (data not shown). It was found that the mean values of the six parameters stay within one standard deviation of the mean values reported in Table 2 , further validating the assumption of keeping a constant.
DISCUSSION
In the time domain, we have used simulated data for DO(t) and DD(t) and shown how the novel hemodynamic model by Fantini (5, 11) can be used to obtain traces of cbf ðtÞ À cmro 2 ðtÞ, in addition to the cbv(t) trace directly derived from DT(t). The temporal traces of cbv(t) and cbf ðtÞ À cmro 2 ðtÞ are descriptive of the underlying physiology of cerebral activation, so that they can be used to investigate the processes associated with brain activity or to detect and assess neurovascular deficits. We have shown that the obtained traces are robust in terms of magnitude and temporal shift for varying t ðvÞ , , with the magnitude change being between 0.08 and 0.09, which is a variability of 10%. For those three parameters of the model, we have found that the time of the peak was also shifted with a variability of $500 ms. The one parameter of the model that resulted in a large variability of cbf ðtÞ À cmro 2 ðtÞ magnitude was the capillary transit time t ðcÞ , in which the magnitude showed a variability of 50%.
However, the t ðcÞ range considered here corresponds to a wide range in the tissue saturation S 0 of 55 to 75%. A measurement of S 0 , as opposed to an assumption based on literature values, can provide a more precise estimate and a smaller uncertainty in the magnitude of cbf ðtÞ À cmro 2 ðtÞ. For example, a range of 62 to 68% for S 0 corresponds to a magnitude variability for cbf ðtÞ À cmro 2 ðtÞ of 15%. As a result, by assuming typical values for the model parameters and by refining these assumptions by appropriate baseline measurements, the model yields reliable traces for the temporal evolutions of cbv(t) and cbf ðtÞ À cmro 2 ðtÞ.
We have assumed the baseline total hemoglobin concentration, T 0 , to be known. From this, we were able to derive timedependent traces for volume changes, cbv(t), as seen in Figure 1b . If however, T 0 is not known while assuming the other model parameters to be known, and we allow a range of values of T 0 from 42 to 79 mM, the magnitude of cbv(t) will vary between 0.05 and 0.09. The corresponding magnitude change in cbf ðtÞ À cmro 2 ðtÞ would show a variability from 0.06 to 0.11. As pointed out for S 0 , this variability can be drastically reduced if absolute values of T 0 are known.
We have further evaluated the dependence on a, where we found that the magnitude of cbf ðtÞ À cmro 2 ðtÞ is only dependent on the product at ðcÞ , which is fixed when keeping the baseline tissue saturation constant at S 0 = 65%. However, as seen in Equation (29), S 0 depends on the relative volumes of the three vascular compartments, which are typically not known. Alternatively, instead of setting the constrain on S 0 , one could set a constrain on the venous saturation, which does not depend on the blood volume fractions being given by S ðvÞ ¼ S ðaÞ e Àat ðcÞ (18) .
Because of the dynamic nature of the novel hemodynamic model, we were able to report cbf ðtÞ À cmro 2 ðtÞ time traces, which showed an earlier rising and peak time than the steadystate version reported in the literature (41, 42) . Also, Fantini (11) reported analytical expressions for the empirical constants g r and g t , which we have used here, allowing us to have access to those values. We found both g r and g t to be $1, which falls within typical literature values, with 0.75 to 1.25 being reported to be a plausible physiological range (42) .
For the frequency domain part of the model, we have used experimental data from a paced breathing paradigm designed to induce hemodynamic oscillations, described by phasors O and D, at multiple frequencies. Using a fitting procedure, the new hemodynamic model yielded the values of six physiological parameters that are related to the cerebral hemodynamics in the microvasculature. -contains the ratio of arterial to venous blood volume, which is expected to be close to 1 in the microvasculature (because of the symmetrical architecture of the arteriolar and venular branches) but may deviate from 1 in the presence of larger arterial or venous vessels within the tissue volume probed by NIRS. The autoregulation cutoff frequency (u ðAutoRegÞ c =ð2pÞ) was found to be robustly determined by fitting the measured CHS spectra with the new model. However, it is important to point out that it is not defined in terms of systemic arterial blood pressure and global cerebral blood flow as typically done in the literature (19, 54) . By contrast, cerebral autoregulation is defined here in terms of the local cerebral blood flow and the microvascular blood volume as described by Equation (19) . This accounts for a specific physiological meaning of the autoregulation cutoff frequency as defined here, and more work is needed to fully characterize its information content and its meaning in relation to the conventional definition of cerebral autoregulation. The asymptotic blood flow to volume ratio (k) (i.e., the ratio between changes in blood flow and changes in blood volume in the absence of autoregulation) cannot be measured by the approach presented here, unless an assumption is made on the venous to total blood volume ratio because it appears in the parameter kCBV ðvÞ 0 =CBV 0 . These six physiological parameters have a diagnostic potential for any neurovascular disorder or brain damage that impact the cerebral hemodynamics and microvascular integrity. Recently, we have demonstrated the clinical applicability of CHS to patients in the hemodialysis unit, for whom we found a significantly slower cerebral microvascular blood flow with respect to a group of healthy controls (55) .
Similar to the time domain case, we have set a = 0.8 s
À1
. We have found that by considering a as a variable parameter and fitting for a does not change the results for the other six parameters, confirming that the reported solutions are insensitive to a. This insensitivity results from the fact that only the ratios of the hemodynamic signals are considered. Because, as shown in the time domain, a together with t ðcÞ determine a magnitude change in the data, the effect is canceled out by taking the ratios of jDj/jOj, jOj/jTj. This lack of sensitivity to absolute changes in D and O makes the fitting procedure robust for determining the other six parameters of the model.
CONCLUSIONS
We have demonstrated how the novel dynamic hemodynamic model by Fantini (11) can be applied to analyze NIRS measurements of time-varying hemodynamics (time domain) and frequency-dependent hemodynamic oscillations (frequency domain). In the time domain, the model can be used to convert measured O(t) and D(t) traces into cbf ðtÞ À cmro 2 ðtÞ traces. We have shown that the magnitude of cbf ðtÞ À cmro 2 ðtÞ is relatively insensitive to the model parameters if the absolute values of baseline total hemoglobin concentration (T 0 ) and tissue saturation (S 0 ) are known. It is inherent to fNIRS data that cbf ðtÞ and cmro 2 ðtÞ cannot be accessed independently. If, however, an independent measurement of cbf ðtÞ is available, a decoupling of cbf ðtÞ and cmro 2 ðtÞ is, of course, possible. In the frequency domain, the model has led to the novel CHS method, which is based on measurements of induced hemodynamic oscillations at multiple frequencies as described by phasors O(u) and D(u). Here, the model can be used to derive the blood transit time in capillaries and venules, the cutoff frequency for cerebral autoregulation, and measures of capillary-to-venous blood volume ratio and arterial-to-venous blood volume changes.
This formulation of the new hemodynamic model results in a practical analytical tool that can find broad applicability in the study of functional brain activation and cerebral hemodynamic assessment with NIRS. In particular, measurements of cerebral blood volume, blood flow, and metabolic rate of oxygen are of paramount importance in studies of brain activation and neurovascular coupling. The quantitative assessment of brain microvascular hemodynamics, cerebral autoregulation, and cerebrovascular reactivity can have farreaching implications in the diagnosis and assessment of a variety of neurovascular disorders, traumatic brain injury, and stroke.
